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ABSTRACT 
Objective. Research has shown that there is an association between Inflammatory Bowel 
Disease, anxiety and mood disorders, however little is known about their association with Eating 
Disorders. In this paper we will present a case of a young female with a comorbid diagnosis of 
Inflammatory Bowel Disease and Eating Disorder, and then discuss the results from a 
systematic review of the literature, describing published cases of patients with the same 
condition. 
Methods. A systematized review of the literature was conducted according to MOOSE 
guidelines. A computerized literature search of MEDLINE, Psyc INFO and EMBASE, and a 
manual search through reference lists of selected original articles were performed to identify all 
published case-reports, case series and studies of Inflammatory Bowel Disease and Eating 
Disorders. 
Results. Fourteen articles were included, encompassing 219 cases, including ours. The vast 
majority were females ranging from 10 to 44 years old. Anorexia Nervosa (n=156) and Crohn’s 
Disease (n=129) was the most frequent combination (n=90) reported in the literature. These 
cases present a poor prognosis because of corticoid refusal, medication abandon and/or 
deliberate exacerbation of IBD symptoms, in the context of trying to lose weight.  
Conclusion. Recent evidence suggests there is a possible association between Inflammatory 
Bowel Disease and Eating Disorders, although the mechanisms involved in its 
ethiopathogenesis are still unknown. To be aware of this association is important because a 
delayed diagnosis of this comorbidity may lead to worse prognosis. Further research and a 
multidisciplinary approach could facilitate earlier diagnosis and provide therapeutic interventions  
 
KEY WORDS.  
Anorexia Nervosa, Bulimia Nervosa, Crohn’s Disease, Eating Disorders, Inflammatory 
Bowel Disease, Ulcerative Colitis. 
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MANUSCRIPT 
 
 
INTRODUCTION 
Inflammatory Bowel Disease (IBD) is a group of conditions/disorders characterized by chronic 
inflammation of the gastrointestinal tract and episodes of relapses and remissions ; especially in 
genetically susceptible individuals exposed to environmental risk factors
1,2
. IBD comprises 
Crohn’s Disease (CD), Ulcerative Colitis (UC), microscopic colitis, indeterminate colitis and 
pouchitis
3
. The prevalence of IBD may be increasing as a result of the low mortality, the earlier 
diagnoses and the longer duration of disease
1
. The registered prevalence of CD varies from 0.6 
to 322 per 100,000 in Europe, and from 4.9 to 505 per 100,000 in case of UC
2
. Most studies 
showed a peak incidence in the second to fourth decade, with the highest incidence amongst 20 
to 29 year old
1,2
. There are not great differences between males and females
1,2
.   
The association between IBD and some mental disorders, especially anxiety and mood 
disorders, has been extensively studied
4-6
. According to the meta-analysis by Neuendorf et al.
6
, 
the prevalence of anxiety and depressive disorders in IBD is 21% and 15% respectively. These 
rates increase up to 35% for anxiety symptoms and 22% for depressive symptomatology. 
However, other mental disorders have received sparse attention in literature. Especially, and 
despite the potential overlap in symptoms, the relationship between eating disorders (ED) and 
IBD has not been widely studied.  
Anorexia Nervosa (AN) and Bulimia Nervosa (BN) have been the main diseases classically 
established as ED
7
. Nevertheless, eating disorder not otherwise specified (EDNOS), which 
includes partial syndromes of AN and BN, has been the most commonly diagnosed
8
 till the 
recent publication of Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-
5)
9
. The point prevalence of EDNOS in a nation-wide community sample of young females was 
2.4%
8
.  In the case of AN and BN, the lifetime prevalence amongst women range from 0 to 
0.9% and from 0.9 to 1.5% respectively
8
. AN has an overall incidence rate of 4.2-8.1 new cases 
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per 100,000 persons per year
10
. In addition, AN presents the highest rate of mortality amongst 
all psychiatric illnesses, with a Crude Mortality Rate of 5.1 deaths per 1000 person-years
8
. 
There are some groups who have studied the role of diet in IBD
11-13
. It has been reported that 
patients with IBD have strong beliefs about some food triggering IBD symptoms
11
, which 
frequently drives them to avoid specific nutrients and/or reduce global intake. This may 
exacerbate malnutrition, and moreover it also may have an impact on their social life, as it 
usually involves events that include eating and drinking
11
. Both, malnutrition and social isolation 
have been related with a significant reduction of quality of life in this population
12
. In addition, 
there are common features in both ED and IBD (see table 1) which may lead to misdiagnosis. It 
has been reported mainly between IBD and AN
14-21
 due to the restrictive pattern
13
, body mass 
index (BMI) reduction, predominance of females and similar age of onset
2,22,23
. Apart from the 
overlapping symptomatology, both conditions can also coexist as described in the case below, 
making differential diagnosis more difficult (see table I).  
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Table I. Similarities and differences between the clinical presentation of inflammatory bowel 
diseases and eating disorders. 
 
  IBD ED 
Epidemiology Ratio female:male No differences
2 
CD: 0.34:1 to 1.65:1
2 
UC: 0.51:1  to 1.58:1
2 
Higher in females
22 
AN or BN: 5:1 to 10:1
22 
Age of highest incidence CD or UC: 20-29 y/o
2 
 
AN: 15-19 y/o
23 
BN: 20-24 y/o
23 
    
Common 
signs & 
symptoms 
Diarrhoea 
Due to inflammation 
It could be related to laxative 
abuse 
Nausea and vomiting Due to inflammation It could be self-induced 
Reduced appetite Secondary to abdominal pain and 
cramping, as well as inflammation 
It can be present in AN 
Weight loss and 
malnourished 
(dehydration; anaemia; 
fatigue; amenorrhea in 
women) 
Due to malabsorption Due to reduced food intake 
Postprandial symptoms Bloating 
 
Abdominal pain 
 
Feeling of fullness, meteorism or 
flatulence 
Post-meal pains of the 
epigastrium 
Constipation Due to inflammation (can lead to bowel 
obstruction) 
Due to low food intake 
    
Differential signs and symptoms Fever 
Blood in stool 
Fistula 
Tenesmus 
Fear of abdominal discomfort from 
eating food 
Body image distortion 
Fear to gain weight 
    
Case reported in the literature about 
misdiagnosis and/or differential diagnosis 
between IBD and ED 
Final diagnosis of IBD: 
Gryboski et al. 1968
14 
Metcalfe-Gibson et al. 1978
15 
Hershman et al. 1985
16 
Jenkins et al. 1988
17 
Andant et al. 1999
18 
Blanchet et al. 2002
19 
Markella et al. 2010
20 
Final diagnosis of ED: 
Tylec et al. 2014
21 
 
 
 
 
 
 
   
AN = Anorexia Nervosa; BN = Bulimia Nervosa; CD = Crohn’s Disease; ED = Eating Disorder; 
IBD = Inflammatory Bowel Disease; UC = Ulcerative Colitis.  
 
There is a paucity of research looking at eating attitudes and behaviours in diet-related chronic 
health conditions
24
 and autoimmune diseases such as IBD
25
. Satherley et al.
13
 have recently 
reported higher prevalence of disordered eating symptoms in participants with IBD relative to 
healthy controls. Nevertheless, to our knowledge there is no previous review focusing on 
subjects with IBD fulfilling criteria for a diagnosis of an eating disorder.  Thus, we present a case 
of a young female with a comorbid diagnosis of IBD and ED, and a systematized review of 
published cases of patients with the same condition.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 7 of 25 
 
Case report 
A 20-year-old Caucasian woman, diagnosed with pancolonic and ileal CD at age 17, was 
admitted to the gastroenterology ward for autologous hematopoietic stem cell transplantation. 
She was corticodependent, intolerant to infliximab and required enteral nutrition at admission. 
She had been under exclusive enteral nutrition for 8 months.  She had also history of Primary 
Sclerosing Cholangitis (diagnosed the previous year). She reported irregular menstruation since 
the age of 14 and six months of amenorrhea before admission in relation with weight loss (from 
60 to 47.5 kg in the previous year; height=1.70 metres; BMI=16.4). She lived with her parents 
and her 24-year-old brother. She had abandoned her studies due to her health condition. 
Once admitted, the patient was referred to the liaison psychiatry unit for mood lability. She 
presented fluctuating low mood with loss of interest in her self-care and anxiety symptoms 
related to her condition (i.e. unmanageable fear of leaving home due to difficult accessibility to 
bathrooms). At the age of 19 she had been diagnosed with adjustment disorder and started 
treatment with paroxetine 20 mg/day and alprazolam 0.25 mg/day.  
During her admission, she frequently refused to eat due to early satiety, abdominal pain and 
nausea, despite the gastroenterologist’s recommendation of oral intake. In addition, she also hid 
prescribed medication and did not take it. Since the age of 14 she also reported a selective 
pattern of eating, progressive restriction of food intake, and feeling more comfortable using 
enteral nutrition. She did not describe body image disturbance or fear of gaining weight.  
Considering her BMI, the amenorrhea and the restrictive diet she was finally diagnosed with 
EDNOS. 
 
METHODS 
This systematized review was conducted according to the guidelines for Meta-Analyses and 
Systematic Reviews of Observational Studies (MOOSE)
26
. 
A computerized literature search of MEDLINE, PsycINFO and EMBASE was performed up to 
the 22
nd
 of December 2016. Search strategy: “inflammatory bowel disease” OR “crohn’s 
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disease” OR “ulcerative colitis” OR “microscopic colitis” OR “indeterminate colitis” OR 
“pouchitis” AND “eating disorder” OR “anorexia nervosa” OR “bulimia nervosa”.  
The reference lists of the identified original articles and case reports were also searched 
manually for additional records. Studies were assessed by first author (L.I.), and when in doubt, 
the final decision was made in consultation with a second author.  Some authors were contacted 
to obtain further information. No limitations were placed on language, publication date and 
publication status. 
The following inclusion criteria were used: (I) any data reported about patients with a comorbid 
diagnosis of IBD and AN, BN or EDNOS. The exclusion criteria were: (I) cases reported with 
misdiagnosed IBD or ED, or uncertain diagnosis; (II) reviews and published conference 
abstracts. Case reports and case series were included given the limited number of published 
epidemiological studies addressing this comorbidity. Publications with cases reporting additional 
comorbidities were not excluded. 
Data were extracted from eligible articles according to the inclusion criteria in a pre-specified 
Microsoft Excel spreadsheet. The following information was collected: (I) demographic 
characteristics (including age, gender, number of patients and country of origin); (II) clinical 
characteristics (including type of IBD, age of diagnosis of IBD, type of ED, age of diagnosis of 
ED, first diagnosis, initial symptoms and other comorbidities) and; (III) treatment (including 
drugs and procedures). 
 
RESULTS 
The search strategy identified 495 records, after removing 80 duplicates. 461 were excluded at 
first screening based on titles and abstracts, leaving 34 articles for full text review. Of them, we 
included 14 articles, excluding 20 articles for the reasons listed in Figure I. Amongst the 14 
articles, there were two retrospective cohort studies
27,28
, six case reports
29-34
, and six case 
series
19,35-39
(Table II). 
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Figure I. Flowchart of literature search of comorbid eating disorders in inflammatory bowel 
disease. 
 
 
 
Records identified through 
database searching 
(n= 564) 
Records identified through 
manual searching 
(n= 11) 
Records after duplicated removed 
(n=495) 
Records screened (n=495) 
Full text articles assessed for 
eligibility (n=34) 
Studies included in qualitative 
synthesis (n=14) 
Records excluded by title 
or abstract (n=461) 
Full text articles excluded (n=20) 
- No case report (4) 
- Misdiagnosis (6) 
- Conference abstract (3) 
- Other comorbidities (2) 
- Other topics (5) 
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Table II. Cases reported in the literature with inflammatory bowel disease and eating disorder comorbidity. 
Author, Year Country Type of 
study 
N Sex Age ED IBD Other comorbidities Cortico-
therapy 
ED treatment Psycho-social and 
environmental factors 
reported 
Sreenivasan
35
, 1984 Canada Case report 1 F 17 AN UC  Yes NS  
Anonymous
29
, 1985 USA Case report 1 M 18 EDNOS CD Mitral and aortic valves 
prolapse 
Yes Admission to psychiatric 
unit, and weekly 
psychotherapy sessions 
Overweight in childhood, 
disturbance of family 
relationships 
Meadows & Treasure
36
, 1989 Australia Case report 1 F 23 BN CD  Yes Psychological treatment  
   1 F 17 BN
a
 CD  Yes NS  
Mallet & Murch
37
, 1990 UK Case report 1 M 14 AN UC Glucose 6-phosphate 
dehydrogenase, early 
puberty 
Yes Outpatient psychotherapy, 
dietary regime (and family 
therapy) 
Teased at school for 
overweight, disturbance of 
family relationships 
   1 F 13 AN CD  Yes Admission to psychiatric 
unit, behavioural regime 
and dietary regime 
Teased at school for 
overweight 
Gryboski
38
, 1993 USA Case report 1 F 14 BN
a
 UC Lactose intolerance No NS  
   1 F 17 BN
a
 CD Lactose intolerance, 
obesity 
Yes Outpatient psychotherapy Best friend had BN 
   1 F 14 EDNOS UC Lactose intolerance, mild 
gastritis 
No NS Divorced parents 
Holaday et al.
30
, 1994 USA Case report 1 M 15 EDNOS CD Delayed puberty NS Psychological and family 
therapy 
Teased at school for short 
stature, sexually abused, 
unwed mother 
Rickards et al.
39
, 1994 UK Case report 1 F 15 AN CD Cyclical neutropenia NS Admission to psychiatric 
unit, behavioural therapy 
Divorced parents 
Blanchet & Luton
19
, 2002 France Case report 1 F 25 AN CD  NS Admission to psychiatric 
unit and psychotherapy 
 
Baylé & Bouvard
31
, 2003 France Case report 1 F 16 AN CD  Yes Psychotherapy sessions Teased at school for 
overweight 
Evert et al.
32
, 2005 Germany Case report 1 F 23 AN CD Pancreatic fibrosis and 
focal pancreatic atrophy 
NS No treatment due to death  
Culkin et al.
33
, 2012 UK Case report 1 F 36 BN
a
 CD Obsessive Compulsive 
Disorder, Personality 
Disorder 
NS She discontinued 
psychotherapy sessions 
Abused and neglected in 
childhood 
Erdur et al.
27
,2012 Germany Epidemio-
logical 
cohort  
1 F - AN CD  NS Individual and group 
therapy, art therapy, 
concentrative movement 
therapy and relaxation 
 
  1 F - AN UC  NS  
  1 F - AN CC  NS  
Solmi et al.
34
,2013 Italy  1 F 26 AN CD  Yes Psychodynamic therapy, Criticized at a ballet audition 
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AN = Anorexia Nervosa; BN = Bulimia Nervosa; CC = Collagenous Colitis; CD = Crohn’s Disease; ED = Eating Disorder; EDNOS = Ea ting Disorder Not Otherwise 
Specified; F = female; IBD = Inflammatory Bowel Disease; M = male; NS = Not Specified; UC = Ulcerative Colitis;; 
a
= those using the disease to lose weight 
 
 
dietary program, psycho-
education 
for the body shape 
Wotton et al.
28
, 2016 UK Epidemio-
logical 
cohort 
83 F - AN CD  NS NS  
  62 F - AN UC  NS NS  
  32 F - BN CD  NS NS  
  22 F - BN UC  NS NS  
Our case Spain  1 F 20 EDNOS CD Adjustment Disorder Yes Behavioural and dietary 
regime during admission in 
Gastroenterology Ward 
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A total of 219 patients, including our case, with a comorbid diagnosis of IBD and ED have been 
reported in the scientific literature (Table II). The vast majority were females, with only three 
cases reported on males. The mean ages ranged from 10 to 44. AN (n=156) and CD (n=129) 
were the most prevalent diagnosis amongst ED and IBD respectively. In fact, the comorbidity 
between them, AN plus CD, has been the most frequent combination reported in the literature 
(n=90) (see figure 2 for more details). The index diagnosis was IBD in 106 out of 211 patients, 
while ED was the first diagnosis made in 105 out of 211 (See figure II). There were no data on 
first diagnosis in 8 patients. ED were clinically diagnosed in case reports and in the two 
epidemiological studies they did not report any screening instrument  (the cohorts were from 
subjects with ED). 
Figure II. Distribution of comorbid eating disorder by diagnosis of Inflammatory Bowel Disease 
published in the literature (number of cases) 
 
 
Clinical presentations were reported for seventeen patients with IBD and ED comorbidity: 
weight loss (n=16), abdominal pain (n=12), diarrhoea (n=7), anaemia (n=6), amenorrhoea 
(n=6), self-induced vomiting (n=5), bloody diarrhoea (n=5), asthenia (n=3), anorexia (n=3), 
nausea (n=3), vomiting (n=3), failure to thrive (n=2), hypoproteinaemic or edema (n=2), 
constipation (n=2), cachexia (n=1), early satiety (n=1), dizziness (n=1), dyspnoea (n=1), 
syncope (n=1), dysphagia (n=1) and sore throat (n=1). The two retrospective cohort studies
27,28
 
did not report any sign or symptom. 
90 
65 
1 
36 
23 
3 1 
Crohn's Disease Ulcerative Colitis Collagenous Colitis
Anorexia nervosa
Bulimia nervosa
Eating Disorder No
Otherwise Specified
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Of the seventeen patients described in case reports or case series studies, five of them used 
the IBD symptomatology to potentiate weight loss (it was suspected in another case but not 
confirmed) with methods specified in 4 cases: 1) by taking laxatives; 2) by taking products with 
lactose despite being intolerant to it; 3) by combining both previous methods; and 4) by using 
stoma as a purging device. Improvement is reported only in one case, where AN symptoms 
improved after TNF-α therapy prescribed for CD. In contrast, severe impairment and fatal 
outcomes were reported for most of the patients: five patients required bowel resections, two 
patients developed toxic megacolon and one died as a result of occult perforation of the colon 
and severe cachexia. In relation to the treatment, enteral nutrition (n=4) and parenteral nutrition 
(n=6) were in general well tolerated. Lack of adherence to prescribed treatment was described 
in 6 patients. And among the 10 patients receiving corticosteroid therapy, another six of them 
showed concern or refusal to being treated with corticoids in relation to weight gain.  
 
DISCUSSION 
The main findings of our systematized review focused on comorbidity between IBD and ED are: 
1) CD and AN are the two comorbid disorders more frequently reported; 2) epidemiologically, 
comorbid IBD and ED is mostly reported in young women; and 3) IBD symptoms have been 
reported to be used for potentiating weight loss in some cases.  
Several reported papers that mention IBD and ED are focused on the misdiagnosis between CD 
and AN
14-21
, being the differential diagnosis sometimes difficult to establish. The first case with a 
comorbid diagnosis of IBD and ED was reported by Sreenivasan
35
 in 1984. Since then, other 
authors have reported cases with ED and IBD, and several studies screening ED in patients 
with IBD have been published
24,25,27,40,41
, the most recent one
28
 in 2016. 
The scientific literature suggests that there is an association between ED and IBD, although 
more research is required to confirm this
24,25,28
. The direction of the relationship between IBD 
and ED also remains unclear; it is not known whether IBD leads to the development of an ED, if 
it is the reverse, or if the relationship is bidirectional. Wotton et al.
28
 observed a significant 
elevated risk of being diagnosed with Ulcerative Colitis (UC), five or more years after the first 
admission due to AN. They also reported on a higher risk of CD in patients diagnosed with AN, 
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and vice-versa, within the first year after an admission. Similar results were described in another 
study
25
, where they found that the incidence and lifetime prevalence of CD were increased in 
patients with ED. Regardless of the direction of this link, comorbidity may lead to significant 
delays in diagnosis and complex therapeutic management
19,27,29,30,32,39
. In our case, the patient 
showed abnormal eating behaviours since the age of 14, although the diagnosis of EDNOS was 
not made until she was 20. Although epidemiological studies did not report the age of the 
subjects, from the individual cases descriptions, it seems that this comorbidity should be 
especially considered in the differential diagnosis within younger patients. Additionally, the 
association between IBD and ED may also worsen the prognosis of both conditions
42
 and even 
threaten patient’s life as some examples found in this review. 
Several risk factors have been hypothesized to relate ED with a diagnosis of IBD: delayed 
growth and puberty onset, preoccupation with dietary management, fear of abdominal 
discomfort from eating food, weight and body shape concerns, poor body image, poor emotional 
well-being, disease severity, body shame (e.g. use of colostomy or ileostomy bag), impaired 
personal relationships and physical limitations
43
. With regards to ethio-pathogenesis theories 
that relate both diseases, some explanations have been raised focusing primarily in three 
aspects: 1) role of diet; 2) changes in body shape because of drug therapy for IBD; 3) immune-
inflammatory pathogenesis. 
Regarding the role of diet in patients with IBD, Hughes et al.
11
 has recently validated the Food-
Related Quality of Life-29 questionnaire (FR-QoL-29). This questionnaire has been developed 
specifically for patients diagnosed with IBD to evaluate eating behaviours and dietary changes 
related with the disease and its consequences in terms of quality of life. Relative to this, some 
studies have suggested that these modifications in dietary patterns and gastrointestinal 
symptoms presented in patients with IBD may act as predisposing factors for ED
13,24
. Some of 
these factors are: 
- The subjective perception of patients of some aliments triggering their IBD symptoms 
although scientific evidence is not enough to support this relation
11
. 
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- Dietary recommendations for IBD, which often include hyperphagic diets to compensate 
the malabsorption due to the disease and/or short bowel syndrome after massive bowel 
resections
33
; in order to avoid malnutrition and/or delayed growth in youngers
43
. 
- The need of enteral or parenteral nutrition, required for treatment in some cases, may 
complicate the reestablishment of food intake, as the case we presented and other one 
reported in the literature
31
. 
- Additionally, exacerbations of postprandial abdominal pain, early satiety, anorexia or 
nausea have been described in patients with upper gastrointestinal CD and weight loss, 
which could be specially exacerbated due to the delayed gastric emptying of solids 
shown in AN and CD
38
. 
All this may lead to food avoidance behaviours, modifying normal eating habits and increasing 
weight loss
13,37,39
.  
In relation to secondary effects of treatment, Meadows and Treasure
36
 were the first who 
proposed that changes in body shape due to corticotherapy, could explain a link between ED 
and IBD. The appearance of acne, moon face, oedema, and skin striae are frequent early 
adverse effects associated with a supra-physiological dose of corticosteroids, currently used to 
induce remission in CD
44
. These changes may modify the body shape of the patient and 
increase their weight, resulting in triggering restrictive and/or purgative behaviours to regulate it. 
This theory has been supported by other authors who have described similar cases
31,37,38
 in 
which patients refused prescribed corticosteroids. This time sequence, however, is not 
applicable to the cases where ED is the initial diagnosis
19,29,34,37-39
. Other drugs used for IBD 
treatment, as tacrolimus, have been reported to induce anorexia nervosa-like symptoms in 
children
5,45
.  
In recent years, Solmi et al.
34
 have offered a novelty inmuno-inflammatory hypothesis 
suggesting that proinflammatory cytokines (IL-6 and TNF-α), which levels are increased in CD, 
may be involved in the maintenance of AN symptoms. These substances and hypothalamic 
neuropeptides have common ways in regulating hunger/satiety and energy expenditure. Over-
expression of the IL-6 may contribute to increase levels of anorexigenic peptides (pro-
opiomelanocortin and corticotrophin-releasing hormone) and decrease orexigenic peptides 
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(neuropeptide Y, agouti-related, melanin-concentrating hormone, prepro-orexin)
46
. Additionally, 
IL-6 facilitates satiety by stimulating leptin sensitivity at the hypothalamus. Likewise, TNF-α 
promotes the effect of anorexigenic peptides in inflammatory diseases as IBD
34
. It has been 
also found increased levels of autoantibodies (autoAbs) against peptides related with appetite, 
body weight and suppression of food intake (α-melanocyte-stimulating hormone, oxytocin, 
vasopressin, luteinizing hormone-releasing hormone, adrenocorticotropic hormone) in patients 
with ED as well as in control subjects
47
. Although these autoAbs are not sufficient to cause 
ED
47
, it has been suggested that non-harmful autoAbs may become pathogenic and contribute 
to the development of ED by different mechanisms
47,48
: 1) autoAbs may cross the blood-brain 
barrier and disrupt signalling at the MC4 melanocortin receptor, related with weight regulation; 
2) autoAbs may also interfere with signalling on the MC3 melanocortin receptor of the arcuate 
nucleus, located outside the blood-brain barrier and associated with the control of food intake by 
substances such as neuropeptide Y (NPY); 3) autoAbs may block α-MSH function and supress 
the production of IL-1 and TNF-α, inhibiting food intake; and 4) autoAbs may occupy serotonin-
binding sites and increase its concentration, which is a common feature found in plasma of AN 
patients. In this regard, several studies have described similar features for patients with IBD. It 
has been found that disruption in MC1 melanocortin receptor signalling may lead to worsening 
of colitis in mice
49
. In fact, one study showed a reduction of intestinal inflammation in murine 
models being treated with melanocortin-derived tripeptide α-MSH (KPV)
50
. Lower plasmatic 
levels of NPY have also been found in patients with IBD than in control subjects, suggesting a 
key role of NPY in the development of IBD by interacting with other substances as serotonin 
and somatostatin
51
. Likewise, serum serotonin levels may be associated and correlated with a 
higher pouch endoscopy inflammation in and cuffitis
52
.  
Additionally, another study
53
 showed lower levels of acyl ghrelin IgG autoAbs in patients with AN 
than in healthy subjects. In contrast, ghrelin reactive autoAbs bind mainly to des -acyl ghrelin in 
control subjects. In case of IBD patients, serum ghrelin levels seem to be higher in active 
disease than in IBD patients in remission. These elevated levels correlate with severity of the 
IBD and the activity markers
54
. These features suggest a possible link between gut and brain. 
However, it remains unclear whether these substances play a role in the pathogenesis or 
maintenance of ED
34
. 
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The main limitation of this review is inherent to the publication bias: there are few articles 
focused on this topic and they are mainly case series. Besides, it should be taken into account 
that frequently, published case reports are those with unusual presentations or outcomes due to 
their severity. At the same time, this could also support our view that less severe patients 
suffering this comorbidity could be underreported and/or underdiagnosed. It needs to be also 
highlighted that none of the publications included reported longitudinal prospective data and that 
only one author performed the article selection. Nevertheless, as a strength, to the authors’ 
knowledge this is the first review addressing this comorbidity , exhaustively reviewing all 
published data and suggesting plausible ethiopathegenic mechanisms underlying this 
association. Although literature is scarce and conclusions should be taken cautiously, it is a 
relevant topic in daily clinical practice and its interest is growing in latest years as reflected in 
recent epidemiological studies
24,25,27,28
. 
CONCLUSION 
Recent evidence suggests a possible association between IBD and ED, and some theories and 
risk factors have been proposed in this regard. Nevertheless, the mechanisms involved in its 
ethiopathogenesis are still unknown. To be aware of this condition is important because a 
delayed diagnosis of comorbid IBD and ED may lead to worse prognosis. Considering our 
experience in the management of the case described above and the cases reported by other 
authors, there are some clinical implications that could be of interest for clinicians. First, ED 
diagnosis should be considered in patients with IBD. Second, multidisciplinary approach would 
be recommended in these complex cases to provide an adequate therapeutic intervention. 
Third, screening tools to evaluate eating attitudes and behaviours in patients with IBD could be 
used in daily practice, as for example the Eating Attitude Test – 26
11,55
. Further research, mostly 
prospective studies, is needed to firmly support this link, and to identify clinical and/or biological 
markers which could facilitate earlier diagnosis.  
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HIGHLIGHTS 
1. Symptomatology overlaps between inflammatory bowel disease and eating disorders  
2. Comorbidity should be considered in the differential diagnosis 
3. Crohn’s Disease and Anorexia Nervosa is the most frequent reported comorbidity  
4. A delayed diagnosis of this comorbidity may lead to poorer prognosis 
5. A multidisciplinary approach would be necessary to manage these cases 
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